CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Year-over-year total asset growth rate
| Period | Value |
|---|---|
| Q4 2025 | -3.64% |
| Q3 2025 | -9.60% |
| Q2 2025 | 77.73% |
| Q1 2025 | -18.28% |
| Q4 2024 | -13.27% |
| Q3 2024 | -12.71% |
| Q2 2024 | -13.79% |
| Q1 2024 | -8.48% |
| Q4 2023 | -8.76% |
| Q3 2023 | 5.73% |
| Q2 2023 | -10.84% |
| Q1 2023 | -10.07% |
| Q4 2022 | 15.19% |
| Q3 2022 | -12.92% |
| Q2 2022 | -12.38% |
| Q1 2022 | -12.55% |
| Q4 2021 | -8.57% |
| Q3 2021 | -7.75% |
| Q2 2021 | -7.31% |
| Q1 2021 | 21.05% |
| Q4 2020 | -4.40% |
| Q3 2020 | -6.78% |
| Q2 2020 | -7.83% |
| Q1 2020 | 27.95% |
| Q4 2019 | -8.39% |
| Q3 2019 | -8.08% |
| Q2 2019 | -8.83% |
| Q1 2019 | -2.76% |
| Q4 2018 | -5.31% |
| Q3 2018 | 28.06% |
| Q2 2018 | 0.13% |
| Q1 2018 | -5.33% |
| Q4 2017 | 2.74% |
| Q3 2017 | 10.00% |
| Q2 2017 | 97.80% |
| Q1 2017 | -10.67% |
| Q4 2016 | 3.24% |
| Q3 2016 | -6.76% |
| Q2 2016 | 7.77% |
| Q1 2016 | -2.67% |